The Australian stock market recently experienced a solid performance, buoyed by higher gold and silver prices and a positive close on Wall Street. In the context of these market dynamics, investors might consider exploring opportunities beyond traditional large-cap stocks. Penny stocks, despite their seemingly outdated name, continue to offer intriguing possibilities for those interested in smaller or newer companies with potential growth prospects.

Top 10 Penny Stocks In Australia

Name Share Price Market Cap Financial Health Rating Alfabs Australia (ASX:AAL) A$0.435 A$124.67M ★★★★★☆ Dusk Group (ASX:DSK) A$0.89 A$55.42M ★★★★★★ IVE Group (ASX:IGL) A$2.93 A$451.63M ★★★★★☆ MotorCycle Holdings (ASX:MTO) A$3.04 A$224.54M ★★★★★★ Pureprofile (ASX:PPL) A$0.049 A$57.32M ★★★★★★ Veris (ASX:VRS) A$0.072 A$38.91M ★★★★★★ West African Resources (ASX:WAF) A$3.41 A$3.9B ★★★★★★ Service Stream (ASX:SSM) A$2.15 A$1.32B ★★★★★★ EDU Holdings (ASX:EDU) A$0.875 A$125.94M ★★★★★☆ MaxiPARTS (ASX:MXI) A$2.25 A$124.98M ★★★★★★

Click here to see the full list of 413 stocks from our ASX Penny Stocks screener.

Let's dive into some prime choices out of the screener.

Immutep

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Immutep Limited is an Australian biotechnology company focused on developing innovative Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases, with a market cap of A$663.17 million.

Operations: The company generates revenue primarily from its immunotherapy segment, amounting to A$5.03 million.

Market Cap: A$663.17M

Immutep Limited, an Australian biotechnology company, is advancing its pipeline with promising developments in immunotherapy. Recent positive updates from the Phase I trial of IMP761 for autoimmune diseases and the Phase III TACTI-004 trial for non-small cell lung cancer highlight potential growth avenues. Despite being pre-revenue with A$5.03 million in revenue, Immutep's strategic collaborations and licensing agreements, like the one with Dr. Reddy’s Laboratories for Eftilagimod Alfa (efti), bolster its financial outlook through milestone payments and royalties. The company's robust cash position exceeds its liabilities, providing a stable runway for continued research efforts.

Unlock comprehensive insights into our analysis of Immutep stock in this financial health report. Assess Immutep's future earnings estimates with our detailed growth reports.ASX:IMM Debt to Equity History and Analysis as at Jan 2026

MFF Capital Investments

Simply Wall St Financial Health Rating: ★★★★★★

Overview: MFF Capital Investments Limited is an investment firm manager with a market capitalization of A$2.95 billion.

Story Continues

Operations: The firm generates revenue primarily from its equity investment segment, amounting to A$631.43 million.

Market Cap: A$2.95B

MFF Capital Investments, with a market capitalization of A$2.95 billion, offers an appealing investment profile within the penny stock segment due to its high-quality earnings and reliable 3.6% dividend yield. The firm operates debt-free, ensuring financial stability, while its short-term assets significantly cover both short- and long-term liabilities. Despite experiencing negative earnings growth over the past year, MFF's net profit margins have improved slightly to 68.4%. Recent executive changes include the appointment of Gerald Stack as CEO from January 2026, potentially enhancing strategic leadership given his extensive industry experience.

Get an in-depth perspective on MFF Capital Investments' performance by reading our balance sheet health report here. Review our historical performance report to gain insights into MFF Capital Investments' track record.ASX:MFF Debt to Equity History and Analysis as at Jan 2026

Ora Banda Mining

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Ora Banda Mining Limited is an Australian company focused on the exploration, operation, and development of mineral properties and mining, with a market cap of A$3.09 billion.

Operations: The company generates revenue primarily from its gold mining operations, amounting to A$404.29 million.

Market Cap: A$3.09B

Ora Banda Mining, with a market cap of A$3.09 billion, presents a compelling case in the penny stock arena due to its strong financial metrics and recent inclusion in the S&P/ASX 200 Index. The company's debt is well covered by operating cash flow, and interest payments are comfortably managed by EBIT. Earnings growth has been substantial over the past year at 575%, far outpacing industry averages, while net profit margins have improved significantly to 46%. Despite increased debt levels over five years, Ora Banda maintains more cash than total debt, reinforcing its financial robustness amidst sector volatility.

Click here to discover the nuances of Ora Banda Mining with our detailed analytical financial health report. Review our growth performance report to gain insights into Ora Banda Mining's future.ASX:OBM Financial Position Analysis as at Jan 2026

Taking Advantage

Access the full spectrum of 413  ASX Penny Stocks by clicking on this link. Contemplating Other Strategies? We've found 12 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ASX:IMM ASX:MFF and ASX:OBM.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments